Possible New Therapeutic Strategy for Severe Dengue Disease

by Ramya Rachamanti on August 28, 2019 at 9:25 AM
Possible New Therapeutic Strategy for Severe Dengue Disease

Nafamostat mesylate, a tryptase inhibitor, can treat severe dengue disease, according to the team of researchers from Duke-NUS Medical School.

The dengue virus infects about 390 million people globally each year, causing substantial morbidity and mortality. While most patients experience dengue fever or a mild form of the disease, a small percentage develops dengue haemorrhagic fever (DHF), the more severe occurrence of dengue wherein blood 'leaks' from ruptured blood vessels.


This can lead to dengue shock syndrome (DSS) - the final stage of DHF - where the circulatory system fails, sending the body into bleeding and shock, which is fatal without prompt treatment. How dengue patients go on to develop these severe conditions had not been clearly understood and, as a result, no targeted treatments have been developed to prevent hemorrhaging or reverse shock in infected patients.

"We discovered that, in severe cases, a particular enzyme called tryptase cuts the proteins that act as seals between blood vessel cells, resulting in blood vessel leakage and shock during dengue infection," said Assistant Professor Ashley St. John, from Duke-NUS' Emerging Infectious Diseases Programme, corresponding author of the study.

Based on this finding, the team wanted to know if a drug specific to inhibiting tryptase could be used to treat the hemorrhaging. Nafamostat mesylate, a clinically-approved tryptase inhibitor with a good safety profile, was tested using preclinical models. They found that administration of this drug, which is already used for the treatment of certain bleeding complications in some countries, prevented vascular leakage in the dengue model.

Even delayed treatment with the drug was significantly effective in reducing dengue vascular leakage in a preclinical model of severe disease. The team also observed tryptase levels were very high in the blood of severe dengue patients who experienced DHF/DSS, but low in patients who easily recovered, affirming the link between high levels of the enzyme and severe dengue disease.

"Currently, only supportive care is available to patients suffering from severe dengue disease, with no targeted treatment for this potentially fatal condition. We believe our findings raise the possibility of developing new targeted treatments for dengue and, specifically, one that might be able to prevent shock," added Asst Prof St. John.

"We are currently experiencing a surge in dengue cases in Singapore," said Professor Patrick Casey, Senior Vice Dean for Research at Duke-NUS. "This timely study by our researchers not only holds out hope for a promising new strategy to treat severe dengue disease, but could also have broader implications for the treatment of other haemorrhagic diseases."

The study authors say the next step is to conduct clinical trials to test if tryptase inhibitors can reverse dengue vascular leakage and prevent shock in humans.

Source: Eurekalert
Font : A-A+



Recommended Readings

Latest Dengue News

Increased Temperatures Pose Growing Dengue Risk
In April, the WHO issued a warning that climate change could trigger a worldwide surge in mosquito-borne diseases, including dengue, Zika, and Chikungunya.
Dengue Infections Surge Past 13,000 in Bihar
Over the last 24 hours, there has been a notable increase in dengue patients, surpassing the total number of cases in Bihar, which now exceeds 13,000.
Lucknow Sees Alarming Spike With 38 New Dengue Cases Within a Day
Dengue fever outbreak in Lucknow: The cumulative count of dengue cases in Lucknow has now reached 1,308.
Dengue Outbreak Grips Kolkata as Cases Skyrocket Over the Past Week
Dengue Cases in Kolkata: The number surpasses the 1,102 cases reported in the preceding week. The total cases for the current season have now reached 7,422.
Dengue Crisis Deepens in Bengal as Cases Surpass 50,000 Threshold
The dengue situation in Bengal has reached a critical stage, with the number of cases exceeding the 50,000 mark.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Possible New Therapeutic Strategy for Severe Dengue Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests